QA: Nanoviricides INC in us_pharma/2012

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001379006_2013_Nanoviricides_INC.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001379006, Nanoviricides INC

  xvar xval
0 AssetsCurrent 14,589,159
1 IntangibleAssetsNetIncludingGoodwill 425,807
2 PropertyPlantAndEquipmentNet 614,842
3 remainder_Assets 0
4 LiabilitiesCurrent 1,779,615
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 1,815,816
9 ResearchAndDevelopmentExpense 4,265,933
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -125,458
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 15,629,808
1 Liabilities 1,779,615
2 Expenses 6,081,749
3 Revenues 0
4 StockholdersEquity 13,850,193
5 NetIncome -6,207,207
6 ComprehensiveNetIncome -6,207,207
7 BaseVar 11,808,315
8 EconomicCapitalRatiobeforeLimitedLiability 2.76
9 EconomicCapitalRatio 3.52

Edgar->Model Mapping

Feature Distribution

Change over Time